Solid Biosciences Inc.
3.12
0.03 (0.97%)
At close: Jan 15, 2025, 12:45 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -1.27 -0.7 -2.59 -4.37 -1.55 -11.92 -13.99 -20.2 -68.22
PS Ratio n/a 5.66 13.72 n/a n/a n/a n/a n/a n/a
PB Ratio 0.97 0.22 0.90 2.98 2.24 7.12 -12.3 -5.16 -6.44
P/FCF Ratio -1.28 -0.45 -2.36 -6.85 -1.85 -11.43 -16.02 -21.21 -103.49
P/OCF Ratio -1.3 -0.47 -2.4 -6.96 -1.93 -12.7 -16.87 -21.62 -103.49
OCF/S Ratio n/a -12.1 -5.71 n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.21 0.13 0.01 0.04 0.09 0.01 n/a n/a n/a
Quick Ratio 8.94 9.76 9.18 6.49 4.72 10.31 6.27 5.82 4.00
Current Ratio 8.94 9.76 9.43 6.49 4.72 10.31 6.27 5.82 4.00
Asset Turnover n/a 0.03 0.06 n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.76 -0.31 -0.35 -0.68 -1.44 -0.6 0.88 0.26 0.09
Return on Assets (ROA) -0.58 -0.25 -0.31 -0.53 -1.12 -0.54 -0.68 -0.53 -0.11
Return on Capital (ROIC) -0.69 -0.45 -0.35 -0.6 -1.4 -0.6 -0.84 -0.76 -0.16
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a 70.25% -331.27% n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a -809.36% -529.54% n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a -1.06K% -530.01% n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a -1.32K% -530.5% n/a n/a n/a n/a n/a n/a
FCF Margin n/a -1.25K% -580.36% n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a -1.20K% -508.74% n/a n/a n/a n/a n/a n/a

Create Price Alert on SLDB

Your price alert will notify you when the stock price is above 3.12.

Add to Watchlist